Johnson & Johnson failed in developing an all-metal hip implant to forecast key flaws that led to its recall in 2010, a project manager told jurors in the first of 10,000 lawsuits over the device to go to trial.
Johnson & Johnson failed to warn doctors of the risks of defective metal hip implants that it didn’t test properly, a lawyer told a Los Angeles jury in the first of 10,000 lawsuits over the device to go to trial.
One year after Johnson & Johnson pulled 93,000 metal hip implants from the market, the company internally estimated that 37 percent of the devices would fail within 4.6 years, according to newly unsealed court records.
Johnson & Johnson, which is fighting more than 10,000 lawsuits over its recalled hip implants, is negotiating a potential settlement with patients that may eventually total more than $2 billion, according to five people familiar with the matter.
The U.S. will clean a Vietnam War site contaminated with an Agent Orange byproduct for the first time since fighting ended 37 years ago, boosting ties with a former enemy that blames the herbicide for poisoning millions.
Army Sergeant Jeremy Barnhart says anyone wanting to know what it’s like to deal with the U.S. Department of Veterans Affairs can get a clue from the FedEx packages that land on the front porch of his San Antonio home.
Monsanto Co., the world’s biggest seed company, agreed to settle all pending litigation relating to dioxin contamination from a plant in Nitro, West Virginia, that produced Agent Orange herbicide decades ago.
BP Plc and plaintiffs suing over the 2010 Gulf of Mexico oil spill are discussing a $14 billion accord that would be funded with money originally set aside by the company for out-of-court settlements, according to three people familiar with the talks.